HANA Oncolyzer                  Sanofi Open Innovation Forum                                  Feb 12, 2013                ...
Why an Interdisciplinary Cooperation?2      ■ Charité is a key-player in medical research      ■ Hasso Plattner Institute ...
Demo I: HANA Oncolyzer    Patient Search and Details3    HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Sch...
Demo II: HANA Oncolyzer    Analysis of Patient Cohorts4    HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and S...
International Research Initiative    “HANA Oncolyzer”5      ■ International research initiative        for exchanging rele...
Join the HANA Oncolyzer6      ■ Join our international research initiative      ■ Improve cancer treatment with your exper...
Thank you for your interest!    Keep in contact with us.7    Dr. Christian Regenbrecht                                    ...
Upcoming SlideShare
Loading in …5
×

HANA Oncolyzer -- Sanofi Open Innovation Forum Feb. 12, 2013

1,248 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,248
On SlideShare
0
From Embeds
0
Number of Embeds
318
Actions
Shares
0
Downloads
13
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Überleitungzur Analytical Demo
  • Überleitungzur Analytical Demo
  • HANA Oncolyzer -- Sanofi Open Innovation Forum Feb. 12, 2013

    1. 1. HANA Oncolyzer Sanofi Open Innovation Forum Feb 12, 2013 Dr. Christian Regenbrecht and Institute of Pathology, Charité Berlin Dr. Matthieu-P. SchapranowChair of Prof. Hasso Plattner, Hasso Plattner Institute
    2. 2. Why an Interdisciplinary Cooperation?2 ■ Charité is a key-player in medical research ■ Hasso Plattner Institute is academic institute for “IT Systems Engineering” with research in the field of in-memory database technology ■ SAP is a multinational software vendor for enterprise applications with expertise in processing big data ■ Interdisciplinary cooperation between doctors, researchers, and IT experts ■ In-memory technology as key-enabler for real-time analysis of steady increasing patient data HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Schapranow, Feb 12, 2013
    3. 3. Demo I: HANA Oncolyzer Patient Search and Details3 HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Schapranow, Feb 12, 2013
    4. 4. Demo II: HANA Oncolyzer Analysis of Patient Cohorts4 HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Schapranow, Feb 12, 2013
    5. 5. International Research Initiative “HANA Oncolyzer”5 ■ International research initiative for exchanging relevant tumor data to improve treatment ■ In-Memory Technology as key-enabler for real-time analysis of tumor data in seconds instead of hours ■ Information available at your fingertips: In-Memory Technology on mobile devices (iPad) ■ Interdisciplinary cooperation between medical doctors, researchers, and software engineers ■ Global partners: Charité, SAP, HPI HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Schapranow, Feb 12, 2013
    6. 6. Join the HANA Oncolyzer6 ■ Join our international research initiative ■ Improve cancer treatment with your experiences ■ Build a global cancer database to support doctors and researchers ■ Create individual analytical queries in real-time with the help of In-Memory Technology ■ Access data mobile at any time and anywhere worldwide ■ Give feedback to drive innovation ■ Support the war against cancer disease! HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Schapranow, Feb 12, 2013
    7. 7. Thank you for your interest! Keep in contact with us.7 Dr. Christian Regenbrecht Dr. Matthieu-P. Schapranow christian.regenbrecht@charite.de schapranow@hpi.uni-potsdam.de http://j.mp/schapranow Institute for Pathology & LFGC Hasso Plattner Institute Charité – Universitätsmedizin Berlin Enterprise Platform & Integration Concepts Christian RA Regenbrecht Matthieu-P. Schapranow Charitéplatz 1 August-Bebel-Str. 88 10117 Berlin, Germany 14482 Potsdam, Germany HANA Oncolyzer, Sanofi Open Innovation Forum, Regenbrecht and Schapranow, Feb 12, 2013

    ×